Salarius Pharmaceuticals, Inc.

Clinical-stage biopharma developing targeted protein therapies for cancer and viral diseases.

SLRX | NDAQ

Overview

Corporate Details

ISIN(s):: US79400X4043 (+1 more)
LEI:
Country:: United States of America
Address:: 2450 HOLCOMBE BLVD, 77021 HOUSTON
Website:: https://salariuspharma.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for patients with cancer and other diseases with high unmet medical needs. The company's technology aims to correct the dysregulated gene expression that drives disease progression. Its pipeline is built on two primary drug classes: targeted protein inhibitors (TPIs) and targeted protein degraders (TPDs). The lead TPI candidate, seclidemstat (SP-2577), is in Phase 1/2 clinical trials for solid and hematologic cancers like leukemias and lymphomas. The company's TPD candidate, SP-3164, is in IND-enabling studies. Following a merger with Decoy Therapeutics, Salarius is also advancing peptide therapeutics for cancer and respiratory viruses.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Salarius Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Salarius Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Salarius Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Evaxion A/S Develops AI-powered, personalized vaccines for cancer and infectious diseases.	United States of America	EVAX
Evogene Ltd. AI-powered platform designing life-science solutions for health, ag, and industrial sectors.	Israel	EVGN
Evogene Ltd. AI-powered computational biology developing products for health, agriculture, and industry.	United States of America	EVGN
Evotec SE A drug discovery partner accelerating medicine creation from R&D to manufacturing for pharma/biotech.	United States of America	EVO
EXACT Therapeutics AS Biopharma firm using ultrasound to enhance drug delivery for oncology via its ACT® platform.	Norway	EXTX
FAN Communications Inc. Offers performance-based advertising and CPA solutions via Japan's largest affiliate network.	Japan	2461
F&M CO.,LTD. Back-office outsourcing & consulting in accounting, finance, and HR for SMEs & sole proprietors.	Japan	4771
Foremost Clean Energy Ltd. Canadian explorer of uranium and lithium for the clean energy sector.	United States of America	FMST
Forte Biosciences, Inc. Clinical-stage biopharma developing FB102 for autoimmune diseases like celiac, vitiligo, & alopecia.	United States of America	FBRX
Fortrea Holdings Inc. Global CRO managing clinical trials for the biopharmaceutical and medical device industries.	United States of America	FTRE